£2.05m
−2%vs Nov 2024Active14461527Private limited companyLondon
NEURENTIS PLC
Significant control: Stephane Mery (25–50%), Dimitri Dimitriou (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Neurentis PLC sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
NEURENTIS PLC is an active private limited company (company number 14461527) incorporated on 4 November 2022, registered in London. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest full accounts cover the period ending 30 November 2025, showing net assets of £2.05m and cash of £50k, with 3 employees on average. Net assets fell 2% on the prior period (£2.09m).
Peer position · net assets
By net assets it sits in the top quarter of 143 comparable companies in London (median £100, upper quartile £10k).
02
Ownership and control
- Dr Stephane Mery
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr Dimitri Dimitriou
- owns 25–50% of shares
- holds 25–50% of voting rights
- Franco Di Muzio
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 4 November 20223 yrs ago
- Next accounts due
- 30 August 2027in 311 days
- Confirmation statement due
- 18 November 2026in 26 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- SIC 21200
- Manufacture of pharmaceutical preparations
- Accounts type
- Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£50k
+33%vs Nov 2024Not reported
3
No changevs Nov 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2025 | £2.05m | £50k | — | £24k | — | −£43k | 3 |
| 30 November 2024 | £2.09m | £37k | — | £16k | — | −£37k | 3 |
| 30 November 2023 | — | — | — | — | — | — | — |
Current ratio2.95Current assets ÷ creditors within one year
Cash per employee£17kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £2,052,222 at 30 November 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 2.95
- Three or more accounting periods on record3 periods on record
- Incorporated two to five years agoIncorporated 4 November 2022
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 311 days
- Confirmation statement duein 26 days
- Accounts period endNet assets £2.05m · full accounts
- Accounts period endNet assets £2.09m · full accounts
- Accounts period end
- Incorporated
08
Similar companies in London
- WELLROS PHARMACEUTICALS LTD.London · inc. Nov 2022
- VEIRULENCE LTDLondon · inc. Nov 2022
- AJN INTERNATIONAL GROUP LIMITEDLondon · inc. Nov 2022
- HGK PHARMACEUTICALS LTDLondon · inc. Oct 2022
- TRES ALCHEMIX LTDLondon · inc. Oct 2022
- DP GROUP LTDLondon · inc. Oct 2022
All companies incorporated on 4 November 2022 · in Nov 2022.
09
Reminders for NEURENTIS PLC
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.